| Patents for C07D 473 - Heterocyclic compounds containing purine ring systems (11,932) |
|---|
| 06/29/1995 | CA2179282A1 Pharmaceuticals |
| 06/28/1995 | EP0659209A1 Cancer therapy utilizing malignant cells |
| 06/28/1995 | EP0659082A1 Use of cytochrome p450 inhibitors for inhibiting the metabolism of nitrogen substituted acridine |
| 06/22/1995 | WO1995016450A1 Use of pentoxifyllin in the treatment of multiple sclerosis |
| 06/22/1995 | CA2176848A1 Use of pentoxifyllin in the treatment of multiple sclerosis |
| 06/21/1995 | EP0658564A1 Electroluminescent compounds and intermediates in their synthesis |
| 06/21/1995 | CN1028993C Nucleic acid derivatives |
| 06/15/1995 | WO1995015964A1 Nucleoside derivative |
| 06/14/1995 | EP0656778A1 ENANTIOMERICALLY PURE $g(b)-D-DIOXOLANE-NUCLEOSIDES |
| 06/14/1995 | DE4342131A1 2-Amino-6-chloro-purine prodn. from guanine |
| 06/08/1995 | WO1995015164A1 Use of theophylline for the manufacture of a medicament for the treatment of asthma |
| 06/01/1995 | WO1995014707A1 N-2 substituted purines |
| 05/30/1995 | US5420276 Analogs of oxetanyl purines and pyrimidines |
| 05/30/1995 | US5420136 Eradication of pathogenic biological contaminants using non-azo naphthalimide dyes |
| 05/26/1995 | WO1995014008A1 Substituted 5-ring heterocycles, their preparation and their use |
| 05/26/1995 | CA2169643A1 Substituted 5-ring heterocycles, their preparation and their use |
| 05/24/1995 | EP0654473A1 Cyclopropane derivatives and antiviral agents containing the same |
| 05/24/1995 | EP0654037A1 Antiretroviral enantiomeric nucleotide analogs |
| 05/24/1995 | EP0654033A1 Asymmetrically substituted xanthine with adenosine-antagonistic properties |
| 05/24/1995 | EP0654031A1 Stereoselective synthesis of nucleoside analogues using bicyclic intermediate |
| 05/19/1995 | CA2136159A1 Cyclopropane derivatives and antiviral agents containing the same |
| 05/18/1995 | WO1995013277A1 6-oxo-nucleosides useful as immunosuppressants |
| 05/18/1995 | WO1995013074A1 Use of 2-amino purine derivatives for the treatment and prophylaxis of human herpes virus 7 infection |
| 05/18/1995 | WO1995013073A1 Use of 2-amino purine derivatives for the treatment and prophylaxis of human herpes virus 6 infections |
| 05/18/1995 | CA2175897A1 6-oxo-nucleosides useful as immunosuppressants |
| 05/17/1995 | EP0652880A1 Improved process for preparing xanthine derivates, in particular 1,3-dipropyl-8-(3-oxocyclopentyl)-xanthine |
| 05/10/1995 | EP0651750A1 Tetracyclic compounds process and intermediates for their preparation and their use as antitumour agents |
| 05/10/1995 | EP0651642A1 Use of 1,3-dicyclopropymethyl-8-amino-xanthine for the treatment and prevention of type ii diabetes mellitus and obesity |
| 05/09/1995 | US5414096 Chemical intermediates; DNA viruses |
| 05/09/1995 | US5414000 Antiviral pyrinyl substituted tetrahydropyrans |
| 05/04/1995 | WO1995011904A1 Novel a1 adenosine receptor agonists and antiagonists |
| 05/04/1995 | WO1995011685A1 2',3'-dideoxy-4'-thioribonucleosides as antiviral agents |
| 05/02/1995 | US5412097 Heterocyclic compounds bearing acidic functional groups as angiotensin II antagonists |
| 05/02/1995 | US5411929 Thermally-processable image recording materials including substituted purine compounds |
| 04/27/1995 | DE4415196C1 Improved process for the preparation of 2-amino-6-chloropurine and 2-acylamino-6-chloropurines |
| 04/26/1995 | EP0649411A1 Boronated compounds |
| 04/25/1995 | US5410033 Converting diol groups of nuclosides to mesylate or tosylate groups, reacting with alkali or alkaline telluride or selenide to produce desired olefinic unsaturation at 2',3'position in sugar moiety of nucleosides |
| 04/25/1995 | US5409935 Xanthine derivatives for the treatment of secondary nerve cell damage and functional disorders after cranio-cerebral traumas |
| 04/25/1995 | US5409934 Xanthine derivatives |
| 04/20/1995 | WO1995010506A1 1n-alkyl-n-arylpyrimidinamines and derivatives thereof |
| 04/20/1995 | CA2174080A1 1n-alkyl-n-arylpyrimidinamines and derivatives thereof |
| 04/18/1995 | US5407815 R-(-)-1-(5-hydroxyhexyl)-3-methyl-7-propylxanthine, a process for its preparation and pharmaceuticals containing this compound |
| 04/13/1995 | WO1995009855A1 Amino acids esters of penciclovir and brl 44385 |
| 04/13/1995 | WO1995009839A1 Cycloalkanediols and their use in preparing chiral compounds |
| 04/13/1995 | WO1995009632A1 Use of penciclorin for the treatment of post-therapeutic neuralgia |
| 04/13/1995 | CA2172805A1 Cycloalkanediols and their use in preparing chiral compounds |
| 04/12/1995 | EP0647849A2 Detecting the presence of analytes in a sample |
| 04/05/1995 | EP0646596A1 Nucleic acid binding oligomers having C-branches for therapy and diagnosis |
| 04/05/1995 | EP0646595A1 Nucleic acid binding oligomers having C-branches for therapy and diagnosis |
| 04/05/1995 | EP0646125A1 1,5-anhydrohexitol nucleoside analogues and pharmaceutical use thereof |
| 04/05/1995 | CN1028106C Therapeutic nucleosides |
| 03/30/1995 | WO1995008541A1 Conformationally locked nucleoside analogues |
| 03/23/1995 | WO1995007907A1 Nucleoside derivatives, methods for the manufacture thereof and specific polyclonal and monoclonal antibodies of said derivatives |
| 03/23/1995 | WO1995007901A1 Substituted tetronic acids useful for treating hiv and other retroviruses |
| 03/23/1995 | DE4332041A1 Use of pentoxifylline for the treatment of granulomatous and fibrotic pulmonary disorders |
| 03/23/1995 | CA2168757A1 Substituted tetronic acids useful for treating hiv and other retroviruses |
| 03/22/1995 | EP0644193A2 Process for preparing 2-acetylamino-6-chloropurine |
| 03/21/1995 | US5399775 Process for preparing substituted cyclobutanes |
| 03/21/1995 | US5399688 Caffeine recovery from activated carbon |
| 03/21/1995 | US5399590 Treatment of skin tumors, rheumatic diseases |
| 03/21/1995 | US5399554 Viricides |
| 03/16/1995 | WO1995007287A1 2' OR 3'-DEOXY AND 2'-DIDEOXY-β-L-PENTAFURANONUCLEOSIDE COMPOUNDS, METHOD OF PREPARATION AND APPLICATION IN THERARY, ESPECIALLY AS ANTI-VIRAL AGENTS |
| 03/16/1995 | WO1995007281A1 A process for the preparation of 9-(2-hydroxy)-ethoxymethyl-guanine |
| 03/16/1995 | WO1995007049A1 Diagnostic uses of hydrazinoadenosines |
| 03/16/1995 | CA2171283A1 A process for the preparation of 9-(2-hydroxy)-ethoxymethyl-guanine |
| 03/15/1995 | CN1027896C Antiviral, highly water soluble, stable, crystalline salts of 2'-3'-dideoxyinosine monohydrate, 2'3'-dideoxy-2',3'-didehydrothymidine monohydrate and 2',3'-dideoxy-2'-Fluoroinosine hemihydrate |
| 03/14/1995 | CA2131760A1 Nucleic acid-binding oligomers possessing c-branching for therapy and diagnostics |
| 03/14/1995 | CA2131755A1 Nucleic acid-binding oligomers possessing n-branching for therapy and diagnostics |
| 03/08/1995 | EP0641344A1 8-substituted anthines as phosphodiesterase inhibitors |
| 03/07/1995 | US5395836 8-tricycloalkyl xanthine derivatives |
| 03/02/1995 | CA2130891A1 Shoulder support-type of firewood carrier having built-in multiple handles and a hooking component |
| 03/01/1995 | EP0640342A2 Pentoxifylline and/or depogen for improving the tissue antioxidant status |
| 03/01/1995 | EP0640091A1 Synthesis of nucleotide monomers |
| 03/01/1995 | EP0640085A1 Fused imidazole and triazole derivatives as 5-ht1 receptor agonists |
| 03/01/1995 | EP0640084A1 6-AMINO SUBSTITUTED IMIDAZO 4,5-b]PYRIDINES AS ANGIOTENSIN II ANTAGONISTS |
| 03/01/1995 | EP0502043B1 Utilization of xanthines, optionally incorporated in liposomes in order to help the pigmentation of skin or hair |
| 02/28/1995 | US5393883 Ribonucleotide reductase inhibitors |
| 02/28/1995 | US5393878 Pyrimidine nucleosides having cyclopentafuran skeleton |
| 02/28/1995 | US5393755 Polycyclic guanine derivatives |
| 02/22/1995 | EP0639080A1 Non-azo naphthalimide dyes and uses for same |
| 02/22/1995 | EP0639055A1 Methods of treating obesity with purine related compounds |
| 02/21/1995 | US5391739 Adenosine antagonists |
| 02/21/1995 | US5391733 Synthesis intermediates for 2-amino-6-halogenopurines |
| 02/21/1995 | CA1334508C Method of inhibiting the activity of leukocyte derived cytokines |
| 02/15/1995 | EP0344288B1 Method of inhibiting the activity of leukocyte derived cytokines |
| 02/14/1995 | US5389641 Fused heterocyclic compounds, having angiotensin II antagonistic activity |
| 02/14/1995 | US5389637 2-formylamino-6-halogenopurine |
| 02/14/1995 | US5389634 Imidazole derivatives having angiotensin II receptor antagonistic activity |
| 02/07/1995 | US5387684 Isoindazole compound |
| 02/03/1995 | CA2129274A1 Pharmaceutical composition |
| 02/02/1995 | WO1995003304A1 Novel 9-n-bicyclic nucleoside agents useful as selective inhibitors of proinflammatory cytokines |
| 01/25/1995 | CN1097757A Process for preparing tea natural alkaloid-caffeine |
| 01/25/1995 | CN1097545A Insect control with substituted oxadiazole and thiadiazole compounds |
| 01/18/1995 | EP0633886A1 Pharmaceutically active bicyclic-heterocyclic amines |
| 01/17/1995 | US5382580 N9 morpholino derivatives of 7,8-disubstituted guanines |
| 01/12/1995 | WO1995001370A1 Higher order structure and binding of peptide nucleic acids |
| 01/12/1995 | WO1995001369A1 Double-stranded peptide nucleic acids |
| 01/12/1995 | CA2166462A1 Double-stranded peptide nucleic acids |
| 01/12/1995 | CA2166461A1 Higher order structure and binding of peptide nucleic acids |
| 01/05/1995 | WO1995000516A1 Novel chemical compounds having pde-iv inhibition activity |